A comparison of anti-CD20 chimeric antigen receptors in targeting B-cell malignancies

被引：0
|
作者：
Britton, R. [1 ]
French, R. [1 ]
Glennie, M. [1 ]
机构：
[1] Univ Southampton, Southampton, Hants, England
来源：
IMMUNOLOGY | 2013年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [21] Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
    Davis, TA
    Czerwinski, DK
    Levy, R
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (03) : 611 - 615
  • [22] Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
    Pagel, JM
    Hedin, N
    Subbiah, K
    Meyer, D
    Mallet, R
    Axworthy, D
    Theodore, LJ
    Wilbur, DS
    Matthews, DC
    Press, OW
    [J]. BLOOD, 2003, 101 (06) : 2340 - 2348
  • [23] Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
    Okroj, Marcin
    Osterborg, Anders
    Blom, Anna M.
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (06) : 632 - 639
  • [24] Chimeric Antigen Receptor Therapy for B-cell Malignancies
    Porter, David L.
    Kalos, Michael
    Zheng, Zhaohui
    Levine, Bruce
    June, Carl
    [J]. JOURNAL OF CANCER, 2011, 2 : 331 - 332
  • [25] Anti-Tumor Effects of Anti-CD20 Chimeric Antigen Receptor Therapy in Canine B Cell Lymphoma Patients
    Panjwani, M. Kazim
    Gnanandarajah, Josephine S.
    MaloneyHuss, Martha A.
    Mason, Nicola J.
    [J]. MOLECULAR THERAPY, 2016, 24 : S296 - S296
  • [26] Significantly targeting rituximab resistant B-cell lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells.
    Chu, Yaya
    Ayello, Janet
    Yahr, Ashlin
    Katz, Jared
    Lo, Lowrence
    Flowers, Allyson
    Cairo, Mitchell S.
    [J]. CANCER RESEARCH, 2013, 73
  • [27] Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies
    Peggs, Karl S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1667 - 1670
  • [28] Subcutaneous Injections of Low Doses of Humanized Anti-CD20 Veltuzumab for Treatment of Indolent B-Cell Malignancies
    Negrea, O. George
    Allen, Steven L.
    Rai, Kanti R.
    Elstrom, Rebecca
    Abassi, Rashid
    Farber, Charles M.
    Teoh, Nick
    Horne, Heather
    Wegener, William A.
    Goldenberg, David M.
    [J]. BLOOD, 2009, 114 (22) : 1446 - 1446
  • [29] Stereotype Antigen Receptors in B-Cell Malignancies
    Biderman, Bella
    Julhakyan, Hunan
    Koroleva, Darya
    Zvonkov, Evgeniy
    Nikitin, Evgeniy
    Sudarikov, Andrey
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S284 - S284
  • [30] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    T Oyama
    Y Kagami
    M Seto
    Y Morishima
    [J]. Leukemia, 2001, 15 : 1667 - 1667
12345